NewMarket
NEU
905.83
-20.45
-2.21%
NewMarket
US · NEU
#1616 by market cap
Listed 1970
905.83
-20.45
-2.21%
Live - 5344 symbols - heartbeat 59s ago
· 2026-10-08 05:23
Pre-market
905.50
-0.04%
After-hours
905.83
0.00%
- Market cap
- 8.33B
- P/E (TTM)i
- 19.49
- P/Bi
- 4.53
- EPSi
- 44.44
- Div yieldi
- 1.30%
- 52W posi
- 82%
Reader sentiment
Are you bullish or bearish on NEU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.10, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.20% YoY
Margins
- Gross margin
- 31.46%
- Operating margin
- 19.95%
- Net margin
- 15.31%
Key ratios & quality
- Enterprise valuei
- 9.15B
- PEG ratioi
- 1.35
- Altman Z-Scorei
- 5.10
PEG uses trailing P/E against the 3-year net income growth rate (14.42%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.29B | 2.19B | 2.01B | 2.36B | 2.76B | 2.70B | 2.79B | 2.73B |
| Gross profit | 585.36M | 629.87M | 595.03M | 547.71M | 640.50M | 772.51M | 886.35M | 857.40M |
| Selling & admin expenses | 152.40M | 148.08M | 142.86M | 145.97M | 145.11M | 151.47M | 171.41M | 181.58M |
| Research & development | 140.29M | 144.47M | 140.37M | 143.95M | 140.25M | 138.00M | 124.90M | 132.09M |
| Operating profit | 292.67M | 337.32M | 311.80M | 257.78M | 355.14M | 483.05M | 590.04M | 543.73M |
| Pretax profit | 290.29M | 331.59M | 331.29M | 247.55M | 347.73M | 488.96M | 584.11M | 560.56M |
| Tax | 55.55M | 77.30M | 60.72M | 56.64M | 68.20M | 100.10M | 121.69M | 141.82M |
| Net profit | 234.73M | 254.29M | 270.57M | 190.91M | 279.54M | 388.86M | 462.41M | 418.75M |
| Basic EPS | 20 | 23 | 25 | 18 | 28 | 40 | 48 | 44 |
| Diluted EPS | 20.34 | 22.73 | 24.64 | 17.71 | 27.77 | 40.44 | 48.22 | 44.44 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 700.95M | 698.51M | 690.31M | 635.40M | 669.72M | 747.09M |
| Gross profit | 236.02M | 220.95M | 209.64M | 190.78M | 220.88M | 242.43M |
| Selling & admin expenses | 42.98M | 45.43M | 43.94M | 49.23M | 46.01M | 48.38M |
| Research & development | 33.18M | 32.37M | 35.02M | 31.52M | 31.64M | 30.39M |
| Operating profit | 159.87M | 143.15M | 130.68M | 110.03M | 143.23M | 163.67M |
| Pretax profit | 164.11M | 147.69M | 135.61M | 113.15M | 151.65M | 170.34M |
| Tax | 38.16M | 36.44M | 35.34M | 31.87M | 33.59M | 36.59M |
| Net profit | 125.95M | 111.24M | 100.27M | 81.29M | 118.07M | 133.75M |
| Basic EPS | 13 | 12 | 11 | 9 | 13 | 15 |
| Diluted EPS | 13.26 | 11.84 | 10.67 | 8.65 | 12.62 | 14.54 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 813.42M | 879.40M | 898.08M | 1.39B | 1.19B | 1.04B | 1.03B | 1.06B |
| Cash & ST investments | 73.04M | 144.40M | 125.17M | 459.22M | 68.71M | 111.94M | 77.48M | 77.60M |
| Inventory | 396.34M | 365.94M | 401.03M | 498.54M | 631.38M | 456.23M | 505.43M | 502.26M |
| Total assets | 1.70B | 1.89B | 1.93B | 2.56B | 2.41B | 2.31B | 3.13B | 3.49B |
| Total current liabilities | 271.30M | 308.90M | 312.46M | 725.09M | 423.89M | 364.16M | 374.48M | 419.28M |
| Short-term debt | -- | 14.04M | 13.41M | 365.14M | 15.57M | 15.07M | 15.34M | 16.21M |
| Long-term debt | 765.81M | 642.94M | 598.85M | 789.85M | 1.00B | 643.62M | 971.28M | 883.39M |
| Total liabilities | 1,207,367,000.00 | 1,202,034,000.00 | 1,174,051,000.00 | 1,796,307,000.00 | 1,644,411,000.00 | 1,231,810,000.00 | 1,667,958,000.00 | 1,714,222,000.00 |
| Total equity | 489.91M | 683.10M | 759.82M | 762.13M | 762.41M | 1.08B | 1.46B | 1.78B |
| Retained earnings | 671.22M | 843.88M | 932.27M | 844.36M | 834.40M | 1.10B | 1.43B | 1.67B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.12B | 1.07B | 1.10B | 1.06B | 1.06B | 1.15B |
| Cash & ST investments | 118.25M | 70.26M | 102.46M | 77.60M | 73.16M | 93.60M |
| Inventory | 489.76M | 494.85M | 512.17M | 502.26M | 494.96M | 523.55M |
| Total assets | 3.23B | 3.19B | 3.23B | 3.49B | 3.50B | 3.62B |
| Total current liabilities | 396.26M | 402.07M | 410.49M | 419.28M | 417.26M | 510.76M |
| Short-term debt | 16.30M | 17.17M | 16.91M | 16.21M | 16.14M | 17.97M |
| Long-term debt | 990.56M | 841.83M | 783.10M | 883.39M | 939.61M | 854.83M |
| Total liabilities | 1,713,428,000.00 | 1,582,806,000.00 | 1,543,794,000.00 | 1,714,222,000.00 | 1,771,758,000.00 | 1,782,667,000.00 |
| Total equity | 1.52B | 1.61B | 1.69B | 1.78B | 1.73B | 1.84B |
| Retained earnings | 1.48B | 1.54B | 1.62B | 1.67B | 1.63B | 1.74B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 197.91M | 337.21M | 284.15M | 165.34M | 108.62M | 576.82M | 519.59M | 568.97M |
| Depreciation & amortization | 71.76M | 87.56M | 84.00M | 84.32M | 82.29M | 78.01M | 116.96M | 122.42M |
| Free cash flow | 123.27M | 277.78M | 190.84M | 86.40M | 52.45M | 528.53M | 462.27M | 491.33M |
| Dividends paid | -80.45M | -81.68M | -83.42M | -85.91M | -84.26M | -85.03M | -95.90M | -105.93M |
| Stock buybacks / issuance | -232.02M | 0 | -101.43M | -196.22M | -207.47M | -42.86M | -31.91M | -77.22M |
| Ending cash balance | 73.04M | 144.40M | 125.17M | 83.30M | 68.71M | 111.94M | 77.48M | 77.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 120.31M | 161.08M | 142.41M | 145.17M | 124.03M | 162.12M |
| Depreciation & amortization | 28.78M | 28.49M | 33.10M | 32.05M | 31.66M | 31.80M |
| Free cash flow | 107.30M | 144.80M | 122.07M | 117.17M | 99.68M | 134.75M |
| Dividends paid | -26.06M | -25.84M | -25.84M | -28.19M | -27.96M | -27.59M |
| Stock buybacks / issuance | -57.06M | -20.15M | 0 | 0 | -125.57M | -861.00K |
| Ending cash balance | 118.25M | 70.26M | 102.46M | 77.60M | 73.16M | 93.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 42.92 | 43.28 | 37.44 | 25.03 | 36.56 | 42.13 | 36.30 | 25.75 |
| ROA %i | 13.74 | 14.17 | 14.15 | 8.48 | 11.22 | 16.44 | 16.94 | 12.60 |
| ROIC %i | 20.76 | 20.67 | 20.62 | 12.66 | 15.96 | 22.79 | 23.37 | 16.94 |
| 5-year avg ROE %i | 47.91 | 47.19 | 42.90 | 36.75 | 37.05 | 36.89 | 35.49 | 33.15 |
| EBIT margin %i | 13.85 | 16.47 | 17.78 | 11.96 | 13.85 | 19.50 | 23.02 | 22.03 |
| FCF / sales %i | 5.38 | 12.68 | 9.49 | 3.67 | 1.90 | 19.59 | 16.59 | 18.03 |
| Current ratioi | 3.00 | 2.85 | 2.87 | 1.91 | 2.81 | 2.85 | 2.75 | 2.53 |
| Quick ratioi | 1.43 | 1.55 | 1.48 | 1.17 | 1.23 | 1.49 | 1.26 | 1.19 |
| Debt / assetsi | 45.43 | 37.92 | 34.68 | 48.18 | 45.23 | 31.77 | 33.84 | 27.97 |
| LT debt / equityi | 157.38 | 102.60 | 86.50 | 113.82 | 140.76 | 66.71 | 71.41 | 54.01 |
| Interest coveragei | 11.86 | 12.34 | 13.58 | 8.23 | 10.88 | 14.09 | 11.18 | 15.12 |
| Revenue CAGR (3Y) %i | 2.27 | 2.24 | -2.93 | 0.96 | 8.07 | 10.30 | 5.75 | -0.48 |
| Net income CAGR (3Y) %i | -0.54 | 1.46 | 12.41 | -6.66 | 3.21 | 12.85 | 34.30 | 14.42 |
| FCF CAGR (3Y) %i | -4.50 | 9.67 | 26.59 | -11.17 | -42.63 | 40.43 | 74.90 | 110.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 35.85 | 33.61 | 29.23 | 25.75 | 25.17 | 25.02 |
| ROA %i | 14.99 | 15.08 | 13.95 | 12.60 | 12.15 | 12.67 |
| ROIC %i | 20.43 | 20.57 | 18.86 | 16.94 | 16.40 | 17.29 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.75 | 23.84 | 22.70 | 22.03 | 21.75 | 22.12 |
| FCF / sales %i | 17.21 | 18.89 | 19.85 | 18.03 | 17.96 | 17.27 |
| Current ratioi | 2.84 | 2.66 | 2.68 | 2.53 | 2.55 | 2.25 |
| Quick ratioi | 1.47 | 1.30 | 1.32 | 1.19 | 1.23 | 1.12 |
| Debt / assetsi | 32.94 | 28.75 | 26.65 | 27.97 | 29.10 | 25.96 |
| LT debt / equityi | 69.01 | 55.92 | 49.99 | 54.01 | 57.93 | 50.15 |
| Interest coveragei | 12.65 | 14.02 | 15.03 | 15.12 | 15.51 | 16.92 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Petroleum additives is the largest reported line at 90.43% of revenue, across 3 reported segments.
- The next-largest line, Specialty Materials, is a distant second at 8.99% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Petroleum additives90.43%
Specialty Materials8.99%
All other0.58%
Quote time 2026-10-08 05:23:50 · For reference only, not investment advice and not tailored to your situation.